30 Mar
17 Mar
We have rediscovered an interesting article published by Cosmetic Surgery Times in July 2008.
Mark Solomon, M.D., F.A.C.S., of Bala Cynwyd, PA, a clinical associate professor of surgery, Drexel University College of Medicine, Philadelphia, and medical director for LaserTight, explains that the Bleph Makeover procedure takes a different approach to lower lid blepharoplasty.
This is a simple office procedure performed under local anesthesia, minimum of downtime and a lasting effect with the results comparable to transconjunctival blepharoplasty. It needs to prove the test of time, and it’s not for every patient. The new device is made by EyeTight (LaserTight LLC; Philadelphia, PA), and it is FDA cleared for use in lower lid blepharoplasty.
“Unlike Fraxel or CO2, both of which are surface treatments, for instance, the EyeTight procedure is under the surface,” Dr. Solomon says. “We use local anesthesia, it’s performed in the office in about 15 minutes, and the patient is on his or her way with minimal downtime.” Using a 980 nm laser energy delivered through a 20-gauge EyeTight endoprobe, a puncture is made, the probe is inserted, and the fat bags under the skin are vaporized. The probe, about the size of a typical catheter, is removed, and the procedure is done. “The skin then shrinks, because the fat underlying it is gone — so the skin shrinks secondarily,” Dr. Solomon explains.
LaserOffers.com comment
We have checked the EyeTight website today and were quite disappointed to see that there is no further information about this laser and the Bleph Makeover. The current trend in laser technology development is to make versatile devices to provide multiple procedures. Devices for niche applications, especially the ones that can be done by other devices or by hand, typically have hard time surviving the test of time and market competition. We will keep track of this laser and additional data and peer reviewed studies, whic may come out in the future.
17 Mar
Syneron Medical Ltd. develops, markets and sells elos combined-energy medical aesthetic devices. At last week’s American Academy of Dermatology 67th Annual Meeting in San Francisco Syneron introduced eMatrix skin resurfacing device for darker skin types. It is the only fractional device capable of safely treating patients with skin of color (skin types V and VI on the Fitzpatrick skin classification scale). The eMatrix opens the in-demand fractional ablative treatment market to a larger patient base.
Named first prize winner in the device category for its industrial design by the Israel Ministry of Industry, Trade & Labor, the stylish and functional eMatrix utilizes Matrix RF technology, the world’s first RF-only fractional technology for ablation and skin resurfacing. Clinical studies currently in process using eMatrix’s Matrix RF technology reveal the unique ability to treat skin of color due to the RF-based energy applied to the skin. Launched in December 2008, results of Matrix RF treatments with the eMatrix device include skin rejuvenation, wrinkle reduction and skin tightening.
Fractional treatments are one of the fastest-growing areas of aesthetic procedures. In 2008 alone, the volume of fractional skin rejuvenation procedures was estimated to have grown 200 percent from 2007, according to a May 2008 study by Medical Insights. By 2010, the number of treatments is anticipated to double the number of procedures carried out in 2008.
LaserOffers.com
Since we do provide in-depth coverage for non-laser technologies, we published the news about eMatrix fractional ablative RF device to help our readers form a better and more complete understanding of the current aesthetic market trends.